Updated Jul 16, 2026
HARRIGAN EDMUND has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
Edmund Harrigan is a corporate director known for his roles at ACADIA Pharmaceuticals Inc. and Incyte Corporation. He has participated in several SEC filings related to his directorship but has not reported any significant stock transactions.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | INCY | INCYTE CORP | A — Grant or award | 255 | $113.36 | $29K |
| 2026-06-10 | INCY | INCYTE CORP | A — Grant or award | 1.6K | $0.00 | |
| 2026-06-01 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 8.1K | — | |
| 2026-04-02 | INCY | INCYTE CORP | A — Grant or award [10b5-1] | 269 | $94.12 | $25K |
| 2025-09-30 | INCY | INCYTE CORP | A — Grant or award | 289 | $84.81 | $25K |
| 2025-06-30 | INCY | INCYTE CORP | A — Grant or award | 367 | $68.10 | $25K |
| 2025-06-10 | INCY | INCYTE CORP | A — Grant or award | 2.5K | $0.00 | |
| 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 9.4K | — | |
| 2025-03-31 | INCY | INCYTE CORP | A — Grant or award | 363 | $60.55 | $22K |
| 2024-10-02 | INCY | INCYTE CORP | A — Grant or award [10b5-1] | 378 | $66.10 | $25K |
Edmund Harrigan is a corporate director known for his roles at ACADIA Pharmaceuticals Inc. and Incyte Corporation. He has participated in several SEC filings related to his directorship but has not reported any significant stock transactions.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live HARRIGAN EDMUND profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.